ADVM - Adverum Biotechnologies, Inc.
4.36
0.100 2.294%
Share volume: 1,023,039
Last Updated: 12-08-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$4.26
0.10
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-12-2024 | 11-04-2024 | 05-14-2025 | 08-12-2025 | 11-12-2025 | |
| Assets | |||||||
| Total Assets | 267.828 M | 253.803 M | 234.375 M | 137.654 M | 96.179 M | 72.401 M | |
| Current Assets | 199.130 M | 179.418 M | 161.080 M | 89.469 M | 48.391 M | 28.909 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 43.720 M | 46.506 M | 60.390 M | 33.922 M | 1.979 M | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 149.608 M | 127.321 M | 92.851 M | 49.161 M | 42.418 M | 26.060 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 13.766 M | 13.047 M | 12.215 M | 11.135 M | 10.811 M | 10.462 M | |
| Other Assets | 54.932 M | 61.338 M | 61.080 M | 37.050 M | 36.977 M | 33.030 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 267.828 M | 253.803 M | 234.375 M | 137.654 M | 96.179 M | 72.401 M | |
| Total liabilities | 85.540 M | 85.774 M | 90.259 M | 111.232 M | 116.398 M | 128.054 M | |
| Total current liabilities | 21.549 M | 22.461 M | 27.657 M | 25.094 M | 31.356 M | 44.749 M | |
| Accounts Payable | 1.897 M | 1.973 M | 2.110 M | 1.819 M | 4.748 M | 12.459 M | |
| Other liabilities | 63.991 M | 63.313 M | 62.602 M | 86.138 M | 85.042 M | 83.305 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 63.991 M | 63.313 M | 62.602 M | 86.138 M | 85.042 M | 83.305 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 182.288 M | 168.029 M | 144.116 M | 26.422 M | -20.219 M | -55.653 M | |
| Common stock | 1.127 B | 1.132 B | 1.135 B | 1.141 B | 1.143 B | 1.156 B | |
| Retained earnings | -944.564 M | -963.040 M | -990.174 M | -1.114 B | -1.163 B | -1.211 B |